PeopleBeatingCancer

Cardiovascular Disease Colon Cancer Survivors

Share Button

How can you reduce cardiovascular disease in Colon Cancer Survivors? By living a heart-healthy lifestyle through nutrition, supplementation, and lifestyle therapies.

There is growing research showing that colon cancer survivors experience higher rates of cardiovascular disease (CVD) than people without a cancer history.

The research below indicates that colon cancer survivors — like other cancer survivors — have a significantly higher risk of cardiovascular disease than people without a cancer history. This increased risk persists long after cancer treatment and involves multiple cardiovascular outcomes, including CHD, stroke, and heart failure.

Shared risk factors, treatment-related cardiotoxicity, and cancer-related biological changes all appear to play roles. These findings underscore the importance of integrated survivorship care that addresses heart health alongside cancer monitoring.

I have posted the video below because it explains the problem of cardiovascular disease in colon cancer survivors, and it explains what to do about it. 

Cardiovascular Disease in the Modern Cancer Survivor

I am a long-term cancer survivor of an incurable blood cancer called multiple myeloma. I was diagnosed with chemotherapy-induced cardiomyopathy in late 2015, fully 15 years after my oncologist prescribed cardiotoxic chemotherapy to me.

The cardio-oncologist prescribed a common heart medication called metoprolol. I think colon cancer survivors may benefit from conventional heart therapies. My purpose in writing this blog is not to condemn conventional heart therapy but rather to promote heart-healthy nutrition, supplementation, and lifestyle.

However, I reacted to the medication and discontinued taking it. I researched evidence-based, heart-healthy therapies that I could pursue on my own, such as exercise, CoQ10, curcumin, omega-3 fatty acids, etc.

I was able to lower my blood pressure, increase my ejection fraction, and stabilize my heart health. I have been able to live without conventional heart medication since 2015.

Again, conventional cardiology should be a part of your long-term survivor plan. I am just saying that evidence-based non-conventional heart health should be included too.

Scroll down the page, post a question or a comment if you’d like to learn more about non-conventional heart health therapies.

Good luck,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Colorectal Cancer Linked with Increased Risk of Cardiovascular Mortality

Researchers urge greater attention to heart health, especially in groups at highest risk

The results showed that people with colorectal cancer were overall 16% more likely to die of cardiovascular causes than people without colorectal cancer. The risk was highest in the first two years after a colorectal cancer diagnosis, with patients facing a 45% increased risk during this period. The elevated risk was especially pronounced among people younger than 50 years of age, who were 2.4 times more likely to die of cardiovascular causes than people in the same age group who did not have colorectal cancer.

Black patients with colorectal cancer faced a 74% increased risk compared with the general population, while males faced a 55% increased risk. Ayaz said that the disparities observed in the study could stem from multiple factors, such as differences in socioeconomic status, geographic location or access to care, and warrant further study and attention.

The heightened risk of cardiovascular death could stem from side effects of cancer treatment, from the cancer itself and the inflammatory processes it causes, or from some other cause or combination of causes, researchers said.

“For therapies that are newer, there is not a lot of data on the side effects and toxicities, but evidence is emerging that they cause cardiovascular toxicity,” Ayaz said. “It is important to identify these problems promptly and take steps to mitigate them.”

Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysis

Background: There have been conflicting studies on the associations between cancer and cardiovascular disease (CVD) risk. The hypothesis of this meta-analysis was to investigate whether cancer survivors had an increased risk of CVD compared to those without cancer based on population-based cohort studies…

Findings: A total of 160 population-based cohort studies involving 49,395,865 participants (9,092,869 cancer survivors vs. 40,302,996 non-cancer controls) were identified. Overall, the HR for CVD in cancer survivors was 1.47 [95% CI, 1.33-1.62] compared with that in non-cancer controls.

Cancer increased the risk of all 17 CVD subtypes, with cancer having the greatest effect on venous embolism, thrombosis or thrombophlebitis (HR, 3.07 [2.03-4.65]) and the least on ischemic heart disease (HR, 1.13 [1.03-1.24]). The increased risk of CVD was consistently shown in cancer survivors of brain, hematological, respiratory, male genital, and breast cancers, whereas no significantly higher CVD risk was observed for other cancer types.

Elevated risk of CVD was consistently shown in subgroup analyses of study design, age at cancer diagnosis, sex, location, follow-up duration, control, disease diagnosis, and therapy. Male and younger cancer survivors had elevated risk of CVD than female and older cancer survivors.

Interpretation: This meta-analysis provides an up-to-date comprehensive global overview that cancer survivors had increased risk of CVD and 17 CVD subtypes than non-cancer controls. CVD risk evaluation and management need to be prioritized in cancer survivors, particularly among male, younger, and specific cancer survivors (brain, hematological, respiratory, male genital, and breast). This study provides supporting evidence that may inform future updates to guidelines for CVD prevention in cancer survivors, highlighting its public health relevance.

cardiovascular disease in Colon Cancer Survivors cardiovascular disease in Colon Cancer Survivors

Leave a Comment:

Popular posts

Multiple Myeloma Diet
 Multiple Myeloma Multiple Myeloma Diet
Feb 15, 2022
Multiple Myeloma Survivor- A Different kind of Second Opinion-
 Multiple Myeloma
Nov 04, 2022
C-B-D Enhances Velcade (BORT)
 integrative therapy Multiple Myeloma
Aug 07, 2022
Are Endometrial Polyps Overtreated?
 pre-cancer
Nov 14, 2021